Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Grey

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Endocrine Pathology|October 6, 2016
The RET E616Q Variant is a Gain of Function Mutation Present in a Family with Features of Multiple Endocrine Neoplasia 2AWilliam Grey, Rosaline Hulse, Anna Yakovleva, et al.
Human Mutation|March 19, 2013
Deficiency of the cyclin-dependent kinase inhibitor, CDKN1B, results in overgrowth and neurodevelopmental delayWilliam Grey, Louise Izatt, Wafa Sahraoui, et al.
Experimental Hematology|March 31, 2025
Ex vivo modelling reveals low levels of CKS1 inhibition boost haematopoiesis via AKT/Foxo1 signallingJuliana Fabiani Miranda, Adam Rogerson, Megan Guthrie, et al.
Nature Communications|November 23, 2017
The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemiaAlessandro Di Tullio, Kevin Rouault-Pierre, Ander Abarrategi, et al.
Hemasphere|March 6, 2023
The CKS1/CKS2 Proteostasis Axis Is Crucial to Maintain Hematopoietic Stem Cell FunctionWilliam Grey, Samantha Atkinson, Beatrice Rix, et al.
Stem Cell Reports|February 13, 2021
Human Erythroid Progenitors Are Directly Infected by SARS-CoV-2: Implications for Emerging Erythropoiesis in Severe COVID-19 PatientsHector Huerga Encabo, William Grey, Manuel Garcia-Albornoz, et al.
Science Translational Medicine|June 22, 2022
CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemiaWilliam Grey, Ana Rio-Machin, Pedro Casado, et al.
Cell|August 26, 2023
Structure of the thrombopoietin-MPL receptor complex is a blueprint for biasing hematopoiesisNaotaka Tsutsumi, Zahra Masoumi, Sophie C James, et al.
Biomacromolecules|October 4, 2023
Hydrogel Cross-Linking via Thiol-Reactive PyridazinedionesCalise Bahou, Richard J Spears, Angela M Ramírez Rosales, et al.
Blood Cancer Journal|August 1, 2018
High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemiaMiriam Marquis, Cyrielle Beaubois, Vincent-Philippe Lavallée, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Endocrine Pathology|October 6, 2016
The RET E616Q Variant is a Gain of Function Mutation Present in a Family with Features of Multiple Endocrine Neoplasia 2AWilliam Grey, Rosaline Hulse, Anna Yakovleva, et al.
Human Mutation|March 19, 2013
Deficiency of the cyclin-dependent kinase inhibitor, CDKN1B, results in overgrowth and neurodevelopmental delayWilliam Grey, Louise Izatt, Wafa Sahraoui, et al.
Experimental Hematology|March 31, 2025
Ex vivo modelling reveals low levels of CKS1 inhibition boost haematopoiesis via AKT/Foxo1 signallingJuliana Fabiani Miranda, Adam Rogerson, Megan Guthrie, et al.
Nature Communications|November 23, 2017
The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemiaAlessandro Di Tullio, Kevin Rouault-Pierre, Ander Abarrategi, et al.
Hemasphere|March 6, 2023
The CKS1/CKS2 Proteostasis Axis Is Crucial to Maintain Hematopoietic Stem Cell FunctionWilliam Grey, Samantha Atkinson, Beatrice Rix, et al.
Stem Cell Reports|February 13, 2021
Human Erythroid Progenitors Are Directly Infected by SARS-CoV-2: Implications for Emerging Erythropoiesis in Severe COVID-19 PatientsHector Huerga Encabo, William Grey, Manuel Garcia-Albornoz, et al.
Science Translational Medicine|June 22, 2022
CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemiaWilliam Grey, Ana Rio-Machin, Pedro Casado, et al.
Cell|August 26, 2023
Structure of the thrombopoietin-MPL receptor complex is a blueprint for biasing hematopoiesisNaotaka Tsutsumi, Zahra Masoumi, Sophie C James, et al.
Biomacromolecules|October 4, 2023
Hydrogel Cross-Linking via Thiol-Reactive PyridazinedionesCalise Bahou, Richard J Spears, Angela M Ramírez Rosales, et al.
Blood Cancer Journal|August 1, 2018
High expression of HMGA2 independently predicts poor clinical outcomes in acute myeloid leukemiaMiriam Marquis, Cyrielle Beaubois, Vincent-Philippe Lavallée, et al.
Pageof 3